ID Management A/S’s Integra LifeSciences IART Stock Holding History

ID Management A/S’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$239K	Hold	6,000	–	–	0.08%	170
2016 Q1	$202K	Hold	6,000	–	–	0.06%	192
2015 Q4	$203K	Buy	6,000 +2,000	+50%	+$62.5K	0.07%	186
2015 Q3	$119K	Buy	+4,000	New	+$125K	0.05%	216

Other funds holding IART

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ID Management A/S's IART Position: Q2 2016 in Review

ID Management A/S held its Integra LifeSciences (IART) position steady in Q2 2016 at 6,000 shares worth $239K. The position accounts for 0.08% of the portfolio, ranked #170.

ID Management A/S first reported a position in IART in Q3 2015 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold IART as of Q2 2016.

ID Management A/S held 6,000 shares of Integra LifeSciences worth $239K as of Q2 2016.
ID Management A/S left its Integra LifeSciences share count unchanged in Q2 2016.
Integra LifeSciences made up 0.08% of ID Management A/S's portfolio in Q2 2016, its #170 holding.
ID Management A/S first reported a position in Integra LifeSciences in Q3 2015 and has held it in 4 quarters since.
211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2016.

Based on ID Management A/S's 13F filing for Q2 2016, filed 14 Jul 2016.